http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170011285-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fd6fdb8cc439061143dc8a966303868 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| filingDate | 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58f64b6ea1637063abf3133fbe6540e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecf7be357dfe809632d01d59c90f53ac |
| publicationDate | 2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20170011285-A |
| titleOfInvention | Pharmaceutical composition for preventing or treating anemia comprising agent targeting EPO receptor as well as PKC as an active ingredient and the use thereof |
| abstract | The present invention provides a pharmaceutical composition for preventing or treating anemia comprising an EPO receptor and a PKC co-target substance as an active ingredient. The EPO receptor and the PKC co-target substance exhibit cell proliferation promoting activity in an EPO-dependent cell line, exhibit anemia mitigation efficacy in an animal model of anemia, exhibit a synergistic effect on EPO activity in erythrocyte colonization, And thus can be used for prevention or treatment of anemia. Therefore, the pharmaceutical composition comprising the EPO receptor and the PKC co-target substance as an active ingredient can be usefully used as a pharmaceutical composition for the prevention or treatment of anemia. |
| priorityDate | 2015-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.